P/E at 30.69 vs Industry's 36.44: What the Data Shows for Cipla Ltd.

1 hour ago

Share Via

A price-to-earnings ratio of 30.69 against an industry average of 36.44. That's a notable discount for Cipla Ltd., previously rated Hold by MarketsMojo, whose rating was reassessed on 2 September 2026. The one-year return of -12.67% trails the Sensex's -10.03%, yet the three-month performance shows a modest gain of 0.81% versus the Sensex's decline of 3.57%. The data paints a nuanced picture of valuation and momentum across timeframes.

Valuation Picture: Discount to Industry P/E

Cipla Ltd. trades at a P/E multiple of 30.69, which is approximately 15.8% below the Pharmaceuticals & Biotechnology industry's average P/E of 36.44. This discount suggests that the market is pricing in either a more cautious outlook on Cipla's earnings growth or perceives higher risks relative to its peers. Given the sector's elevated valuation, this gap could imply that investors are factoring in challenges specific to Cipla Ltd. — Cipla — what is the current rating? — or that the stock offers relative value within the sector's context.

Performance Across Timeframes: Mixed Momentum

Examining returns over various periods reveals a divergence in momentum. Over the past year, Cipla Ltd. has declined by 12.67%, underperforming the Sensex's 10.03% fall. However, the three-month return of 0.81% contrasts with the Sensex's 3.57% drop, indicating a recent relative strength. This short-term resilience is further nuanced by the one-month return of -4.78%, slightly worse than the Sensex's -4.28%, and a one-week return of -1.33% versus the Sensex's -0.67%. The 1-day performance is inline with the sector, with a modest 0.14% gain compared to the Sensex's 0.09% rise.

This pattern suggests that while Cipla Ltd. has faced headwinds over the longer term, recent months have seen some stabilisation or recovery — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — a question that the technical indicators may help answer.

Moving Average Configuration: Bearish Technical Setup

The technical picture for Cipla Ltd. remains challenging. The stock is trading below all key moving averages: 5-day, 20-day, 50-day, 100-day, and 200-day. This configuration typically signals a sustained downtrend, with no immediate signs of technical recovery. The stock has also recorded a consecutive four-day losing streak, falling 1.73% during this period, reinforcing the bearish momentum.

Such a setup often indicates that short-term rallies may be met with resistance, and the stock could remain under pressure until it breaks above these moving averages. This technical weakness contrasts with the modest three-month outperformance versus the Sensex, highlighting the complexity of the current market dynamics for Cipla Ltd..

Sector Performance Context

The Pharmaceuticals & Biotechnology sector has seen mixed results in the recent earnings season. Out of 28 stocks that have declared results, 13 reported positive outcomes, 11 were flat, and 4 posted negative results. This distribution suggests a broadly stable sector environment with pockets of strength and weakness.

Within this context, Cipla Ltd.’s underperformance over the past year and its current valuation discount may reflect company-specific challenges rather than sector-wide issues. The sector's resilience contrasts with Cipla's recent struggles — should investors in Cipla Ltd. hold, buy more, or reconsider?

Rating Reassessment and Historical Context

Cipla Ltd. was previously rated Hold by MarketsMOJO before its rating was updated on 2 September 2026. The current Mojo Score stands at 38.0, with a Mojo Grade of Sell. This shift in assessment reflects the combination of valuation, performance, and technical factors outlined above.

Looking at longer-term returns, Cipla has outperformed the Sensex over 3 and 5 years, with gains of 10.20% and 42.71% respectively, compared to the Sensex's 9.68% and 26.07%. However, over the 10-year horizon, Cipla's 129.88% return trails the Sensex's 160.16%, indicating that while the company has delivered solid medium-term growth, it has lagged the broader market over the last decade.

Conclusion: A Complex Valuation and Momentum Landscape

The data for Cipla Ltd. reveals a stock trading at a discount to its sector P/E, with mixed performance across timeframes and a bearish technical setup. While the one-year return lags the Sensex, the recent three-month outperformance hints at some stabilisation. The stock’s position below all major moving averages and its recent losing streak suggest caution in the near term.

Within a sector showing a balanced mix of positive and flat results, Cipla’s challenges appear company-specific. The reassessment from Hold to a more cautious rating by MarketsMOJO reflects these complexities — should investors reconsider their stance on Cipla Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE